Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2019-2024
Title: Innovations by Inventor Chen-Lung Lin
Introduction
Chen-Lung Lin is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of lentivirus packaging systems and methods for improving lentivirus production. With a total of 2 patents, his work has the potential to impact cancer treatment and viral research.
Latest Patents
Chen-Lung Lin's latest patents include a lentivirus packaging system that comprises a transfer plasmid with a nucleotide sequence of TAR-reserved-chimeric 5' long terminal repeat (LTR). This system also includes at least one packaging plasmid with sequences encoding TAR RNA binding protein, rev gene, gag gene, and pol gene, along with an envelope plasmid. The innovation allows for higher virus titer and improved transduction rates, enhancing gene delivery efficiency during cell transduction. Additionally, he has developed methods for improving lentivirus production in host cells and for using transduced cells in cancer treatment. His research also explores the propagation of hepatitis C virus using human adipose-derived stem cells, revealing new insights into viral replication and potential therapeutic avenues.
Career Highlights
Throughout his career, Chen-Lung Lin has worked with notable companies such as Frontier Bio-drug Development Limited and Pell Bio-med Technology Co., Ltd. His expertise in biotechnology and virology has positioned him as a key figure in the development of innovative solutions for complex medical challenges.
Collaborations
Chen-Lung Lin has collaborated with talented individuals in his field, including Wei-Chi Lin and Ssu-Yu Chou. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Chen-Lung Lin's contributions to biotechnology, particularly in lentivirus research and hepatitis C virus propagation, highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in cancer therapy and viral research.